TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Infectious Diseases
Studies in the area of infectious diseases reported from J.R. Danko and co-researchers
April 21st, 2009
According to recent research from the United States, "Tumor necrosis factor- inhibitors are important adjunctive therapies for rheumatologic diseases. These agents increase the risk for granulomatous disease." "We present a case of a woman with severe rheumatoid arthritis on infliximab who developed multiple nodular skin lesions. Biopsies grew Mycobacterium marinum," wrote J.R. Danko and colleagues. The researchers concluded: "New lesions developed through therapy, necessitating surgical debulking." Danko and colleagues published their study in Scandinavian Journal of Infectious Diseases (Disseminated Mycobacterium marinum...
Source: TB & Outbreaks Week (2009-04-21)
|
